Presentation TCT 2013 Shorter Is Better: New Insights From OPTIMIZE, PARIS, and Other Studies Presenter: Roxana Mehran October 31, 2013
Presentation TCT 2013 DES Implantation in a Patient with Atrial Fibrillation Presenter: Roxana Mehran October 31, 2013
News Industry News OrbusNeich’s COMBO™ Dual Therapy Stent Featured in TCT 2013 Satellite Symposium October 31, 2013
Presentation TCT 2013 Trading off Ischemic vs. Hemorrhagic Complications of PCI: Implications for Drug and Vascular Access Decision-Making Presenter: Roxana Mehran October 30, 2013
Presentation TCT 2013 The Ongoing Saga of Short DAPT Therapy After DES: Navigating Device Evolution, New Pharmacotherapy, and Changing Clinical Practice Standards Presenter: Roxana Mehran October 30, 2013
Presentation Case 4: Patient with Atrial Fibrillation and DES Presenter: Roxana Mehran October 29, 2013
Presentation TCT 2013 Critical Appraisal and Clinical Implications Presenter: Roxana Mehran October 29, 2013
Presentation TCT 2013 Current Choice of Antiplatelet Therapies in NSTEMI and STEMI Presenter: Roxana Mehran October 28, 2013
Presentation TCT 2013 Editorial Comment: Pharmacological Therapy and Hemodynamic Support in the Shock Patient: Does It Matter? Presenter: Roxana Mehran October 28, 2013
Presentation TCT 2013 Current Drugs and Devices for Primary PCI Presenter: Roxana Mehran October 28, 2013
Presentation TCT 2013 Welcome/ Introductions/ Session Objectives Presenter: Roxana Mehran October 27, 2013
News Industry News Clinical Data for OrbusNeich's COMBO™ Dual Therapy Stent to Be Presented at TCT 2013 October 22, 2013
News Daily News Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina Caitlin E. Cox October 11, 2013
News Daily News High-Risk Subgroups Derive Kidney Protection from Rosuvastatin Caitlin E. Cox October 11, 2013
News Conference News ESC 2013 Meta-analysis: Best Outcomes Seen with Newer-Generation DES in Women Yael L. Maxwell September 02, 2013
Presentation ESC 2013 Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry Presenter: 32040|Roxana Mehran September 01, 2013